Concepedia

Luyang Yao

LY

9

Publications

510

Citations

9

H-Index

2005

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Shanghai Medical College of Fudan University

Luyang Yao is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, radiation oncology, and oncology.

Top concepts

MedicineOncologyPharmacologyRadiation OncologyLung CancerCell BiologyCancer TherapyCell SignalingPharmacotherapySignal Transduction

Publications per year

2005–2025

9

Publications

9

Randomized Phase IIB Trial of Proton Beam Therapy Versus Intensity-Modulated Radiation Therapy for Locally Advanced Esophageal Cancer

Steven H. Lin, Brian P. Hobbs, Vivek Verma et al. · Journal of Clinical Oncology · 2020 · 248 citations · Full text

Phase II Trial of Concurrent Atezolizumab With Chemoradiation for Unresectable NSCLC

Steven H. Lin, Yan Lin, Luyang Yao et al. · Journal of Thoracic Oncology · 2019 · 135 citations · Full text

Concurrent Atezolizumab, Oncology, Phase Ii Trial +7

Final efficacy outcomes of atezolizumab with chemoradiation for unresectable NSCLC: The phase II DETERRED trial

Yufei Liu, Luyang Yao, Neda Kalhor et al. · Lung Cancer · 2022 · 28 citations

Oncology, Unresectable Nsclc, Metronomic Therapy +10

OA01.06 DETERRED: Phase II Trial Combining Atezolizumab Concurrently with Chemoradiation Therapy in Locally Advanced Non-Small Cell Lung Cancer

Steven H. Lin, Daniel L. Clay, Luyang Yao et al. · Journal of Thoracic Oncology · 2018 · 26 citations · Full text

Oa01.06 Deterred, Oncology, Chemoradiation Therapy +7

Identification of extracellular signal-regulated kinase 3 as a new interaction partner of cyclin D3

Maoyun Sun, Yuanyan Wei, Luyang Yao et al. · Biochemical and Biophysical Research Communications · 2005 · 20 citations

Signal Transduction, Signaling Pathway, Molecular Pathway +12

Rows per page

1–5 of 9